Over 100 Claude Code skills were tested to find the most effective tools for devs to build reliable automations and ...
Google's efforts to place more ads in front of users aren't exactly new, as we've seen the company utilize different strategies to achieve that end goal. YouTube started pushing back against people ...
SAN FRANCISCO, April 8, 2026 /PRNewswire/ -- KushoAI, an AI-native platform for API testing and software reliability, has introduced APIEval-20, an open benchmark designed to evaluate how effectively ...
Jake Peterson is Lifehacker’s Tech Editor, and has been covering tech news and how-tos for nearly a decade. His team covers all things technology, including AI, smartphones, computers, game consoles, ...
The latest trends in software development from the Computer Weekly Application Developer Network. SmartBear is a company focused on delivering what it calls “application integrity for modern tech ...
YouTube just launched a new pop-up survey asking viewers if videos look like "AI slop," spurring theories that they're training their own bot. Since Tuesday, instead of asking whether a video was ...
The most basic issue with this approach is that people are not good at spotting AI-generated content, and the gap between human detection and AI capability is widening fast. Early AI content had ...
I have eight years of experience covering Android, with a focus on apps, features, and platform updates. I love looking at even the minute changes in apps and software updates that most people would ...
As the calendar has turned to February, the arrival of the 2026 NTT INDYCAR SERIES season is getting real as teams prepare for two major preseason tests in the next two weeks. Ten teams are heading to ...
Don't pull your hair out when ads interrupt your videos. I've found a few ways to skip or limit them.
YouTube's title A/B testing is now rolling out globally to all creators with access to advanced features. Creators can test up to three titles, thumbnails, or title-thumbnail combinations. Tests run ...
Cdymax Pharma has been slapped with a warning letter from the FDA outlining two observations against the Bangalore, India-based API maker, both linked to testing shortfalls. The letter comes in ...